777 abstracts found.



Results filter

Characterisation of lymphocyte adhesion molecules expressed by tumour endothelium from colorectal cancer

Year:

Session type:

Elizabeth Hepburn1, Stephen Thomas Ward1, Shankar Suresh1, Rahul Hejmadi2, Tariq Ismail2, Patria F Lalor1
1Centre for Liver Research and NIHR Biomedical Research Unit, Institute for Biomedical Research, University of Birmingham, Birmingham, UK, 2Queen Elizabeth University Hospitals Foundation trust, Birmingham, UK

Parallel functional genetic and compound screens identify WEE1 inhibition as a therapeutic strategy for cancers with defects in Fanconi Anaemia and HR pathways

Year:

Session type:

Marieke Aarts1, Ilirjana Bajrami1, Richard Elliott1, Christopher Lord1, Alan Ashworth1, Nicholas Turner1,2
1Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK, 2Royal Marsden Hospital, London, UK

Cdc42 is required for melanoblast population of the developing mouse embryo

Year:

Session type:

Emma Woodham1, Ang Li1, Ben Tyrrell1, Heather Spence1, Cord Brakebusch2, Laura Machesky1
1Beatson Institute for Cancer Research, Glasgow, UK, 2Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark

Targeting DNA damage repair pathways to modulate pancreatic ductal adenocarcinoma response to DNA damaging agents

Year:

Session type:

Elaina Maginn1, Camila Sousa1, Hani Gabra1, Harpreet Wasan1, Euan Stronach1
1Imperial College London, London, UK

High-sensitivity wide-range HPV genotyping in anal squamous cell carcinoma in a UK cohort (2004-2009): Implications for multi-valent HPV vaccination development

Year:

Session type:

Ivona Baricevic-Jones1, Xiaotong He1, Anthony Oliver1, Charles Bailey2, Jeff Summers2, Lynne Hampson1, Ian Hampson1, Andrew Renehan4,5, Duncan Gilbert3
1Institute of Cancer Studies, University of Manchester, Manchester, UK, 2Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust, Maidstone, UK, 3Sussex Cancer Centre, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK, 4The Christie NHS Foundation Trust, Manchester, UK, 5Faculty Institute of Cancer Sciences, University of Manchester, Manchester, UK

Real-time Electronic Patient Outcome ReporTing of adverse events in UK cancer trials (REPORT-UK)

Year:

Session type:

Kate Absolom1, Beverly Horne1, Simon Pini1, Elaine O'Connell2, Will Crocombe1, Emma Levison1, Gill Booth1, Jane Blazeby2,3, Julia Brown1, Galina Velikova1,4
1University of Leeds, Leeds, UK, 2University of Bristol, Bristol, UK, 3University Hospitals Bristol NHS Foundation Trust, Bristol, UK, 4The Leeds Teaching Hospitals NHS Trust, Leeds, UK

Population based changes in treatment and overall survival for squamous cell cancer (SCC) of the anus – Evidence of impact of the ACT1 trial?

Year:

Session type:

Amy Downing1, Eva Morris1, Araidni Aravani3, Paul Finan2,4, Sarah Lawton3, James Thomas4, John Wilkinson3, David Sebag-Montefiore1,2
1University of Leeds, Leeds, UK, 2Leeds Teaching Hospitals NHS Trust, Leeds, UK, 3Public Health England, London, UK, 4National Cancer Intelligence Network, London, UK

“We are leading the group and the process”– The views and experiences of a patient and carer group involved in a research grant allocation

Year:

Session type:

Ian Lewis1, Anita Howman1, Sioned Pearce1
1Tenovus, Cardiff, UK

Differences in test characteristics between the first two rounds of the English Bowel Cancer Screening Programme

Year:

Session type:

Ben Kearns1, Sophie Whyte1, James Chilcott1
1University of Sheffield, Sheffield, UK

Impact of co-expression of HER family members on prognosis and survival of patients with metastatic colon cancer

Year:

Session type:

Said Abdullah Khelwatty1, Sharadah Essapen1,2, Izhar Bagwan3, Margaret Green3, Alan Seddon1, Helmout Modjtahedi1
1School of Life Sciences, Kingston University London, Kingston, UK, 2St. Lukes Cancer Centre, Royal Surrey County Hospital, Guildford, UK, 3Department of Histopathology, Royal Surrey County Hospital, Guildford, UK

Page 25 of 78« First...25...50...Last »